• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 sFas/sFasL 比值与系统性红斑狼疮(SLE)患者的年龄有关。

Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age.

机构信息

Department of Medicine and Sciences of Aging, University G.d'Annunzio, Chieti, Italy.

出版信息

Arch Gerontol Geriatr. 2009;49 Suppl 1:221-6. doi: 10.1016/j.archger.2009.09.032.

DOI:10.1016/j.archger.2009.09.032
PMID:19836636
Abstract

Fas and Fas ligand (FasL), members of the tumor necrosis factor (TNF) and TNF-receptor (TNFR) families of molecules, are involved in apoptosis. They are expressed in membrane-associated as well as soluble forms (sFas, and sFasL). Apoptotic defects underlie some models of autoimmune diseases, and they have been proposed in the pathogenesis of systemic lupus erythematosus (SLE) a prototypic autoimmune disorder. We measured the serum levels of sFas and sFasL in a series of well characterized SLE patients and devised an index of the two forms which resulted to be associated with age, indicating that apoptosis resistance is modulated during aging, thus explaining the conflicting observations made in previous studies.

摘要

Fas 和 Fas 配体(FasL)是肿瘤坏死因子(TNF)和 TNF 受体(TNFR)家族分子的成员,参与细胞凋亡。它们以膜结合和可溶性形式(sFas 和 sFasL)表达。凋亡缺陷是某些自身免疫性疾病的模型基础,并且已经在系统性红斑狼疮(SLE)这一典型的自身免疫性疾病的发病机制中提出。我们在一系列特征明确的 SLE 患者中测量了血清 sFas 和 sFasL 的水平,并设计了一种这两种形式的指数,结果与年龄相关,表明凋亡抵抗在衰老过程中受到调节,从而解释了以前研究中观察到的相互矛盾的结果。

相似文献

1
Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age.血清 sFas/sFasL 比值与系统性红斑狼疮(SLE)患者的年龄有关。
Arch Gerontol Geriatr. 2009;49 Suppl 1:221-6. doi: 10.1016/j.archger.2009.09.032.
2
Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.癌基因(sFas、Bcl-2)和细胞因子(IL-10、α-TNF)与系统性红斑狼疮活动度的关系。
Anticancer Res. 2001 Jul-Aug;21(4B):3053-9.
3
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.系统性红斑狼疮患者的血清脱氧核糖核酸酶I、可溶性Fas/FasL水平及细胞表面Fas表达:重组人脱氧核糖核酸酶I治疗无效的一种可能解释
Int Immunol. 2009 Mar;21(3):237-43. doi: 10.1093/intimm/dxn142. Epub 2009 Jan 30.
4
Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.在中国人群中,系统性红斑狼疮患者血清可溶性Fas水平升高与器官和组织损伤有关。
Arch Dermatol Res. 2006 Jan;297(7):329-32. doi: 10.1007/s00403-005-0616-2. Epub 2005 Nov 17.
5
Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.慢性肾衰竭患者血清可溶性Fas(CD95)和Fas配体水平分析
J Lab Clin Med. 2000 Oct;136(4):320-7. doi: 10.1067/mlc.2000.109318.
6
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.血清可溶性 Fas 和 Fas 配体 (FasL) 与系统性红斑狼疮结局的相关性。
Lupus Sci Med. 2020 Jun;7(1). doi: 10.1136/lupus-2019-000375.
7
Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.急性肝衰竭患者的可溶性Fas和可溶性Fas配体水平
J Crit Care. 2001 Jun;16(2):59-63. doi: 10.1053/jcrc.2001.25470.
8
Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis.弥漫性腹膜炎并发多器官功能障碍综合征中的可溶性Fas和可溶性Fas配体
Res Commun Mol Pathol Pharmacol. 2004;115-116:235-42.
9
The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.系统性红斑狼疮中T细胞亚群的异常凋亡及白细胞介素-10的可能参与
Cell Immunol. 2005 Jun;235(2):117-21. doi: 10.1016/j.cellimm.2005.08.031. Epub 2005 Oct 13.
10
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?血清可溶性Fas水平升高是否有助于系统性红斑狼疮中活化淋巴细胞的持续存在?
J Autoimmun. 1998 Oct;11(5):457-63. doi: 10.1006/jaut.1998.0233.

引用本文的文献

1
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.血清可溶性 Fas 和 Fas 配体 (FasL) 与系统性红斑狼疮结局的相关性。
Lupus Sci Med. 2020 Jun;7(1). doi: 10.1136/lupus-2019-000375.
2
Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.幼年特发性关节炎患者血清可溶性 Fas(sFas)、可溶性 TRAIL(sTRAIL)升高,可溶性 FasL(sFasL)降低。
Clin Rheumatol. 2017 Dec;36(12):2847-2852. doi: 10.1007/s10067-017-3615-8. Epub 2017 Apr 4.
3
Declining Physical Performance Associates with Serum FasL, miR-21, and miR-146a in Aging Sprinters.
衰老短跑运动员体能下降与血清FasL、miR-21和miR-146a相关。
Biomed Res Int. 2017;2017:8468469. doi: 10.1155/2017/8468469. Epub 2017 Jan 3.